# LY6G6C

## Overview
LY6G6C is a gene that encodes the protein lymphocyte antigen 6 family member G6C, which is part of the Ly6/uPAR family. This family is characterized by the presence of a conserved LU domain, which forms a three-fingered structure stabilized by disulfide bridges. The LY6G6C protein is predicted to be a glycosylphosphatidylinositol (GPI)-anchored protein, suggesting its localization to the cell membrane, where it may participate in cell signaling and communication, particularly within lipid rafts. The protein is involved in various cellular functions, including cell proliferation, migration, and immune cell maturation, and is expressed in fibroblasts, where it is associated with filopodia functions. LY6G6C is located on human chromosome 6 and is evolutionarily conserved, indicating its potential importance in immune-related functions (Loughner2016Organization).

## Structure
LY6G6C is a member of the Ly6/uPAR family, characterized by the presence of a conserved LU domain. This domain features a three-fingered structure stabilized by disulfide bridges formed by conserved cysteine residues, similar to the structure found in snake venom neurotoxins (Loughner2016Organization; Leth2019Evolution). The LU domain typically consists of 60-90 amino acids, with ten cysteine residues forming a specific disulfide-bonded network that contributes to the protein's stability and function (Leth2019Evolution).

LY6G6C is predicted to be a glycosylphosphatidylinositol (GPI)-anchored protein, which suggests it localizes to the cell membrane, potentially within lipid rafts, facilitating interactions with other proteins (Loughner2016Organization). The GPI-anchor domain is encoded by the third exon of the gene, which is typical for Ly6/uPAR family members (Loughner2016Organization).

The protein's primary structure includes a signal peptide encoded by the first exon, while the mature polypeptide is encoded by the last two exons (Loughner2016Organization). Although specific post-translational modifications for LY6G6C are not detailed, proteins in this family often undergo glycosylation, which can affect their function and localization. The exact interacting factors and cellular functions of LY6G6C remain unknown (Loughner2016Organization).

## Function
LY6G6C is a member of the Ly6/uPAR family of proteins, which are characterized by a distinct disulfide bridge pattern forming a three-finger LU domain. These proteins are involved in various cellular functions, including cell proliferation, migration, and immune cell maturation (Loughner2016Organization). LY6G6C is expressed in fibroblasts and is associated with filopodia functions, which are involved in cell movement and signaling (Loughner2016Organization). 

The protein is part of a larger family that often targets nicotinic acetylcholine receptors (nAChRs) and can initiate signaling by interacting with other transmembrane proteins, suggesting a role in cell signaling and communication (Loughner2016Organization). Although specific interacting factors and detailed functions of LY6G6C in healthy human cells are not fully elucidated, its expression pattern and association with cellular structures like filopodia indicate its involvement in cell adhesion and migration processes (Loughner2016Organization). 

LY6G6C is located on human chromosome 6 (6p21) and has a syntenic region in the MHC class III region of mouse chromosome 17, highlighting its evolutionary conservation and potential importance in immune-related functions (Loughner2016Organization).

## Clinical Significance
The LY6G6C gene has been implicated in various clinical conditions due to its role in immune response regulation. Alterations in the expression of LY6G6C have been observed in patients undergoing radiation therapy for tonsil squamous cell carcinoma (TSCC). Specifically, the gene is upregulated in patients with mild or no mucositis, suggesting a protective role against severe mucositis, a common side effect of radiation therapy (Marcussen2018Oral). This upregulation indicates that LY6G6C may serve as a potential biomarker for predicting the severity of mucositis in these patients (Marcussen2018Oral).

In the context of psoriasis, LY6G6C is significantly upregulated in affected skin compared to normal skin, suggesting its involvement in the pathogenesis of this inflammatory skin condition (Shiina2009The). The gene's expression is linked to immune and inflammatory responses, highlighting its potential role in immune-mediated diseases.

While the gene's specific mutations or interactions have not been directly linked to particular diseases in the provided context, its expression patterns suggest a broader involvement in immune system disorders and inflammatory conditions (Loughner2016Organization). Further research is needed to elucidate the precise mechanisms by which LY6G6C contributes to these clinical conditions.

## Interactions
The LY6G6C gene encodes a protein that is part of the lymphocyte antigen 6 complex locus, which is involved in various protein-protein interactions, particularly within the context of preeclampsia pathophysiology. The protein encoded by LY6G6C is part of a cluster that includes LY6G6D, LY6G6F, LY6G5B, and LY6G5C. These proteins are associated with immune system processes and cellular responses, as indicated by STRING database analysis. The interactions are characterized by co-expression, physical interaction, shared protein domains, co-localization, and predicted interactions. Specifically, LY6G6C is involved in protein clusters that exhibit acetylcholine receptor regulator activity and play a role in the regulation of immune responses (Abramova2022Effects).

The LY6G6C protein is a member of the Ly6/uPAR family, which is known for its involvement in cell proliferation, migration, and immune cell maturation. These proteins often interact with nicotinic acetylcholine receptors and can initiate signaling by interacting with other transmembrane proteins, particularly through GPI-anchored proteins that congregate in lipid rafts (Loughner2016Organization). However, specific interactions of LY6G6C with other proteins or nucleic acids are not detailed in the provided context.


## References


[1. (Loughner2016Organization) Chelsea L. Loughner, Elspeth A. Bruford, Monica S. McAndrews, Emili E. Delp, Sudha Swamynathan, and Shivalingappa K. Swamynathan. Organization, evolution and functions of the human and mouse ly6/upar family genes. Human Genomics, April 2016. URL: http://dx.doi.org/10.1186/s40246-016-0074-2, doi:10.1186/s40246-016-0074-2. This article has 158 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s40246-016-0074-2)

[2. (Marcussen2018Oral) Mette Marcussen, Mads Sønderkær, Julie Støve Bødker, Maria Andersen, Søren Nielsen, Charles Vesteghem, Ilse Christiansen, Olav Jonas Bergmann, Martin Bøgsted, Karen Dybkær, Mogens Vyberg, and Hans Erik Johnsen. Oral mucosa tissue gene expression profiling before, during, and after radiation therapy for tonsil squamous cell carcinoma. PLOS ONE, 13(1):e0190709, January 2018. URL: http://dx.doi.org/10.1371/journal.pone.0190709, doi:10.1371/journal.pone.0190709. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0190709)

[3. (Leth2019Evolution) Julie Maja Leth, Katrine Zinck Leth-Espensen, Kristian Kølby Kristensen, Anni Kumari, Anne-Marie Lund Winther, Stephen G. Young, and Michael Ploug. Evolution and medical significance of lu domain−containing proteins. International Journal of Molecular Sciences, 20(11):2760, June 2019. URL: http://dx.doi.org/10.3390/ijms20112760, doi:10.3390/ijms20112760. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms20112760)

[4. (Abramova2022Effects) Maria Abramova, Maria Churnosova, Olesya Efremova, Inna Aristova, Evgeny Reshetnikov, Alexey Polonikov, Mikhail Churnosov, and Irina Ponomarenko. Effects of pre-pregnancy overweight/obesity on the pattern of association of hypertension susceptibility genes with preeclampsia. Life, 12(12):2018, December 2022. URL: http://dx.doi.org/10.3390/life12122018, doi:10.3390/life12122018. This article has 10 citations and is from a poor quality or predatory journal.](https://doi.org/10.3390/life12122018)

[5. (Shiina2009The) Takashi Shiina, Kazuyoshi Hosomichi, Hidetoshi Inoko, and Jerzy K Kulski. The hla genomic loci map: expression, interaction, diversity and disease. Journal of Human Genetics, 54(1):15–39, January 2009. URL: http://dx.doi.org/10.1038/jhg.2008.5, doi:10.1038/jhg.2008.5. This article has 568 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/jhg.2008.5)